Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical TrialYing Mao, Liang-Fu Zhou, Li-Wei Zhang et al.|Chinese Medical Journal|2015Cited by 20